Abnormal pentagastrin response in a patient with pseudohypoparathyroidism

Summary

The case of a 25 year old female patient with pseudohypoparathyroidism type I (PHP) and hypercalcitoninaemia is reported. She was referred to our clinic because of recurrent hypocalcaemia associated with paraesthesias and muscle cramps. She had no signs of Albright hereditary osteodystrophy (AHO), a normal mental status and no family history of hypocalcaemia or any other endocrine disease. Considering the laboratory results with hypocalcaemia, hyperphosphataemia, normal vitamin D and normal creatinine with an extraordinary elevated PTH we diagnosed pseudohypoparathyroidism type I. She had delayed pubertal development with menarche in the age of 20 and hypothyroidism with an atrophic thyroid since she was 22 years old. Calcitonin (CT) was increased and the performed pentagastrin test showed an excessive CT-response with a peak of 725 pg/ml after 2 min. Up to now there are only three reports of patients with PHP and hypercalcitoninaemia. An abnormal pentagastrin response is known to be a specific marker for medullary thyroid carcinoma, but there were no signs of any malignant disease, even after one year of follow-up. The most reasonable cause for the pathological pentagastrin response might be chronic hypocalcaemia. When interpreting a pathological pentagastrin test in a patient with PHP the specifity of the test might be diminished and a careful observational strategy might be appropriate.

Key words:

Pseudohypoparathyroidism - Calcitonin - Pentagastrin test - Hypercalcitoninaemia

References

• 1 Ahmed S F, Dixon P H, Bonthron D T, Stirling H F, Barr D G, Kelnar C J, Thakker R V. GNAS1 mutational analysis in pseudohypoparathyroidism.  Clin Endocrinol (Oxf). 1998;  49 525-531
• 2 Barbot N, Calmettes C, Schuffenecker I, Saint-Andre J P, Franc B, Rohmer V, Jallet P, Bigorgne J C. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.  J Clin Endocrinol Metab. 1994;  78 114-120
• 3 Becker K L, Silva O L, Wisneski L A, Cyrus J, Snider R H, Moore C F, Higgins G A. Limited calcitonin reserve in hyperparathyroidism.  Am J Med Sci. 1980;  280 11-15
• 4 Cohen R, Campos J M, Salaun C, Heshmati H M, Kraimps J L, Proye C, Sarfati E, Henry J F, Niccoli-Sire P, Modigliani E. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).  J Clin Endocrinol Metab. 2000;  85 919-922
• 5 Deftos L J, Powell D, Parthemore J G, Potts J T. Secretion of calcitonin in hypocalcemic states in man.  J Clin Invest. 1973;  52 3109-3114
• 6 Emmertsen K. Medullary thyroid carcinoma and calcitonin.  Dan Med Bull. 1985;  32 1-28
• 7 Engelbach M, Gorges R, Forst T, Pfutzner A, Dawood R, Heerdt S, Kunt T, Bockisch A, Beyer J. Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements.  J Clin Endocrinol Metab. 2000;  85 1890-1894
• 8 Escalada J, Teruel J L, Pavon I, Vila T, Navarro J, Varela C. Normal calcitonin response to pentagastrin stimulation in patients with chronic renal failure.  Acta Endocrinol (Copenh). 1993;  129 39-41
• 9 Frank-Raue K, Hoppner W, Buhr H, Herfarth C, Raue F. Results and follow-up in eleven MEN 2A gene carriers after prophylactic thyroidectomy.  Exp Clin Endocrinol Diabetes. 105 ((Suppl 4)) 1997;  76-78
• 10 Fujii H, Higashi K, Morita M, Sato T. A case of pseudohypoparathyroidism (PHP) associated with multiple hormonal abnormalities.  Jpn J Med. 1984;  23 237-241
• 11 Gejman P, Weinstein L, Martinez M, Spiegel A, Cao Q, Hsieh W, Hoehe M, Gershon E. Genetic mapping of the Gs-a subunit gene (GNAS1) to the distal long arm of chromosome 20 using a polymorphism detected by denaturing gel electrophoresis.  Genomics. 1991;  9 782-783
• 12 Gimm O, Dralle H. C-cell cancer-prevention and treatment.  Langenbecks Arch Surg. 1999;  384 16-23
• 13 Grauer A, Raue F, Ziegler R. Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin [see comments].  Exp Clin Endocrinol Diabetes. 1998;  106 353-359
• 14 Hayward B E, Kamiya M, Strain L, Moran V, Campbell R, Hayashizaki Y, Bonthron D T. The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins.  Proc Natl Acad Sci U S A. 1998;  95 10038-10043
• 15 Jan de Beur S, Ding C, LaBuda M, Usdin T, Levine M. Pseudohypoparathyroidism 1 b: exclusion of parathyroid hormone and its receptors as candidate disease genes.  J Clin Endocrinol Metab. 2000;  85 2239-2246
• 16 Juppner H, Schipani E, Bastepe M, Cole D E, Lawson M L, Mannstadt M, Hendy G N, Plotkin H, Koshiyama H, Koh T, Crawford J D, Olsen B R, Vikkula M. The gene responsible for pseudohypoparathyroidism type I b is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3.  Proc Natl Acad Sci U S A. 1998;  95 11798-11803
• 17 Kageyama Y, Kawamura J, Ajisawa A, Yamada T, Iikuni K. A case of pseudohypoparathyroidism type 1 associated with gonadotropin resistance and hypercalcitoninaemia.  Jpn J Med. 1988;  27 207-210
• 18 Kubler N, Krause U, Wagner P K, Beyer J, Rothmund M. The effect of high parathyroid hormone concentration on calcitonin in patients with primary hyperparathyroidism.  Exp Clin Endocrinol. 1987;  90 324-330
• 19 Lambert P W, Heath Hd, Sizemore G W. Pre- and postoperative studies of plasma calcitonin in primary hyperparathyroidism.  J Clin Invest. 1979;  63 602-608
• 20 Lin H Y, Harris T L, Flannery M S, Aruffo A, Kaji E H, Gorn A, Kolakowski L F, Lodish H F, Goldring S R. Expression cloning of an adenylate cyclase-coupled calcitonin receptor.  Science. 1991;  254 1022-1024
• 21 Marsh D J, McDowall D, Hyland V J, Andrew S D, Schnitzler M, Gaskin E L, Nevell D F, Diamond T, Delbridge L, Clifton-Bligh P, Robinson B G. The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families.  Clin Endocrinol (Oxf). 1996;  44 213-220
• 22 Minagawa M, Watanabe T, Kohno Y, Mochizuki H, Hendy G N, Goltzman D, White J H, Yasuda T. Analysis of the P3 promoter of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene in pseudohypoparathyroidism type 1 b.  J Clin Endocrinol Metab. 2001;  86 1394-1397
• 23 Naveh-Many T, Raue F, Grauer A, Silver J. Regulation of calcitonin gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat.  J Bone Miner Res. 1992;  7 1233-1237
• 24 Orcel P, Tajima H, Murayama Y, Fujita T, Krane S M, Ogata E, Goldring S R, Nishimoto I. Multiple domains interacting with Gs in the porcine calcitonin receptor.  Mol Endocrinol. 2000;  14 170-182
• 25 Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera A. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma [see comments].  J Clin Endocrinol Metab. 1994;  78 826-829
• 26 Parthemore J G, Deftos L J. Calcitonin secretion in primary hyperparathyroidism.  J Clin Endocrinol Metab. 1979;  49 223-226
• 27 Phelan M C, Rogers R C, Clarkson K B, Bowyer F P, Levine M A, Estabrooks L L, Severson M C, Dobyns W B. Albright hereditary osteodystrophy and del(2) (q37.3) in four unrelated individuals.  Am J Med Genet. 1995;  58 1-7
• 28 Raue F, Wieland U, Weiler C, Ziegler R. Enhanced calcitonin secretion in the rat after parathyroidectomy and during chronic calcium deprivation.  Eur J Clin Invest. 1988;  18 284-289
• 29 Raue F, Zink A, Scherubl H. Regulation of calcitonin secretion in vitro.  Horm Metab Res. 1993;  25 473-476
• 30 Simon A, Koppeschaar H P, Roijers J F, Hoppener J W, Lips C J. Pseudohypoparathyroidism type I a. Albright hereditary osteodystrophy: a model for research on G protein-coupled receptors and genomic imprinting.  Neth J Med. 2000;  56 100-109
• 31 Wagar G, Lehtivuori J, Salven I, Backman R, Sivula A. Pseudohypoparathyroidism associated with hypercalcitoninaemia.  Acta Endocrinol (Copenh). 1980;  93 43-48
• 32 Weinstein L S, Gejman P V, Friedman E, Kadowaki T, Collins R M, Gershon E S, Spiegel A M. Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis.  Proc Natl Acad Sci U S A. 1990;  87 8287-8290